Earnings History Data for Repligen Corporation (RGEN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Repligen Corporation

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		RGEN	Repligen Corporation	7,880	0.43	0.34	0.23	Repligen Non-GAAP EPS of $0.43 beats by $0.10, revenue of $154.87M beats by $1.57M [11/12/2024 7:37 AM]	148.52	9.01 (6.46%)	145.00	5.49 (3.94%)	113.50 - 211.13	1,172,961	470,000	15,285
Repligen Q3 2024 Earnings Preview [11/11/2024 1:18 PM] Repligen Non-GAAP EPS of $0.43 beats by $0.10, revenue of $154.87M beats by $1.57M [11/12/2024 7:37 AM] Repligen Reports Third Quarter 2024 Financial Results [2024-11-12 07:30AM] Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings [Nov-11-24 07:04AM]
30-07-2024	PM		RGEN	Repligen Corporation	7,400	0.33	0.33	0.53	Repligen Non-GAAP EPS of $0.33 in-line, revenue of $154M in-line; updates FY24 outlook [7/30/2024 7:40 AM]	160.35	22.35 (16.20%)	149.25	11.25 (8.15%)	110.45 - 211.13	2,159,129	910,000	7,820
Repligen acquiring Tantti Laboratory to boost chromatography applications [7/29/2024 4:35 PM] Repligen to acquire Tantti Laboratory of Taoyuan City, Taiwan [7/29/2024 4:08 PM] Repligen Q2 2024 Earnings Preview [7/29/2024 1:42 PM] Repligen Non-GAAP EPS of $0.33 in-line, revenue of $154M in-line; updates FY24 outlook [7/30/2024 7:40 AM]
01-05-2024	PM		RGEN	Repligen Corporation	9,270	0.28	0.29	0.64	Repligen reports mixed Q1 results; reaffirms FY24 outlook [5/1/2024 7:32 AM]	157.71	-6.49 (-3.96%)	0.0	0.0 (0.00%)	110.45 - 211.13	790,144	520,000	0
Repligen reports mixed Q1 results; reaffirms FY24 outlook [5/1/2024 7:32 AM] Repligen Q1 2024 Earnings Preview [4/30/2024 11:52 AM]
21-02-2024	PM		RGEN	Repligen Corporation	11,640	0.33	0.33	0.68	Repligen misses top-line and bottom-line estimates; initiates FY24 outlook [2/21/2024 7:33 AM]	194.16	-5.56 (-2.79%)	185.00	-14.73 (-7.37%)	110.45 - 211.13	1,070,490	570,000	34,620
Repligen Q4 2023 Earnings Preview [2/20/2024 11:19 AM] Repligen misses top-line and bottom-line estimates; initiates FY24 outlook [2/21/2024 7:33 AM]
31-10-2023	PM		RGEN	Repligen Corporation	6,830	0.23	0.14	0.77	Repligen beats top and bottom line estimates, narrows FY guidance [10/31/2023 7:32 AM]	134.67	20.50 (17.96%)	133.10	18.93 (16.58%)	110.45 - 212.17	2,122,368	970,000	5,867
Repligen Q3 2023 Earnings Preview [10/30/2023 12:35 PM] Repligen beats top and bottom line estimates, narrows FY guidance [10/31/2023 7:32 AM]
02-08-2023	PM		RGEN	Repligen Corporation	9,550	0.53	0.49	0.91	Repligen GAAP EPS of $0.53 beats by $0.21, revenue of $159.2M misses by $6.72M [8/2/2023 7:34 AM]	170.65	3.53 (2.11%)	165.00	-2.12 (-1.27%)	134.64 - 262.26	1,058,961	760,000	16,742
Repligen Q2 2023 Earnings Preview [8/1/2023 1:09 PM] Repligen beats bottom line, but misses topline Q2 estimates, lowers FY guidance [8/2/2023 7:34 AM]
02-05-2023	PM	7:30 AM ET (May 2)	RGEN	Repligen Corporation	8,080	0.64	0.59	0.92	Repligen Non-GAAP EPS of $0.64 beats by $0.05, revenue of $182.66M beats by $1.23M [5/2/2023 7:36 AM]	157.03	3.49 (2.27%)	156.67	3.13 (2.04%)	137.21 - 262.26	988,166	770,000	15,935
Repligen Non-GAAP EPS of $0.64 beats by $0.05, revenue of $182.66M beats by $1.23M [5/2/2023 7:36 AM]
22-02-2023	PM	7:30 AM ET (Feb 22)	RGEN	Repligen Corporation	11,000	0.68	0.58	0.81	Repligen Non-GAAP EPS of $0.68 beats by $0.10, revenue of $186.76M beats by $2.35M [2/22/2023 7:34 AM]	170.12	-7.88 (-4.43%)	186.90	8.90 (5.00%)	137.21 - 262.26	1,858,427	440,000	511
Repligen Non-GAAP EPS of $0.68 beats by $0.10, revenue of $186.76M beats by $2.35M [2/22/2023 7:34 AM] Repligen Q4 2022 Earnings Preview [2/21/2023 12:40 PM]
01-11-2022	PM	7:30 AM ET (Nov 1)	RGEN	Repligen Corporation	10,100	0.77	0.68	0.78	Repligen reports Q3 earnings beat; updates FY22 guidance range above estimates [11/1/2022 7:35 AM]	185.70	3.21 (1.76%)	168.00	-14.49 (-7.94%)	137.21 - 306.98	1,225,863	840,000	38,650
Repligen reports Q3 earnings beat; updates FY22 guidance range above estimates [11/1/2022 7:35 AM] Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands [Nov-01-22 07:00AM] Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? [Oct-31-22 12:10PM]
02-08-2022	PM	7:30 AM ET (Aug 2)	RGEN	Repligen Corporation	11,180	0.91	0.72	0.79	Repligen Non-GAAP EPS of $0.91 beats by $0.20, revenue of $207.63M beats by $18.57M [8/2/2022 7:40 AM]	237.58	25.02 (11.77%)	212.56	0.0 (0.00%)	137.21 - 327.32	1,737,012	670,000	2,881
Repligen Q2 2022 Earnings Preview [8/1/2022 12:58 PM] Repligen Non-GAAP EPS of $0.91 beats by $0.20, revenue of $207.63M beats by $18.57M [8/2/2022 7:40 AM] Repligen surges 11% as it raises fiscal 2022 financial guidance [8/2/2022 11:23 AM] Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance [Aug-02-22 07:30AM]
27-04-2022	PM	7:30 AM ET (Apr 27)	RGEN	Repligen Corporation	8,240	0.92	0.72	0.68	Repligen Non-GAAP EPS of $0.92 beats by $0.20, revenue of $206.4M beats by $20.92M; updates FY22 guidance [4/27/2022 7:34 AM]	157.23	14.67 (10.29%)	136.75	-5.81 (-4.08%)	138.41 - 327.32	1,798,700	630,000	385
Repligen Q1 2022 Earnings Preview [4/26/2022 1:52 PM] Repligen Non-GAAP EPS of $0.92 beats by $0.20, revenue of $206.4M beats by $20.92M; updates FY22 guidance [4/27/2022 7:34 AM] Repligen stock gains ~10% after Q1 results beat; co says posted record revenue in qtr [4/27/2022 10:55 AM] Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance [Apr-27-22 07:30AM] Repligen (RGEN) Beats Q1 Earnings and Revenue Estimates [Apr-27-22 08:45AM] Why Repligen Is Up More Than 10% Today [Apr-27-22 12:10PM]
17-02-2022	PM	7:30 AM ET (Feb 17)	RGEN	Repligen Corporation	10,260	0.81	0.65	0.52	Repligen Non-GAAP EPS of $0.81 beats by $0.16, revenue of $186.52M beats by $8.25M [2/17/2022 7:33 AM]	182.84	-1.20 (-0.65%)	180.20	-3.83 (-2.08%)	162.29 - 327.32	686,356	400,000	976
Repligen Q4 2021 Earnings Preview [2/16/2022 12:31 PM] Repligen Non-GAAP EPS of $0.81 beats by $0.16, revenue of $186.52M beats by $8.25M [2/17/2022 7:33 AM] Medical Stocks' Q4 Earnings on Feb 17: RGEN, IRWD & More [Feb-16-22 09:11AM] Repligen Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-17-22 07:30AM] Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates [Feb-17-22 08:45AM] Repligen's Q4 Earnings Beat Expectations, Issues Solid FY22 Guidance [Feb-17-22 02:56PM]
28-10-2021	PM	7:30 AM ET (Oct 28)	RGEN	Repligen Corporation	15,050	0.78	0.64	0.40	Repligen EPS beats by $0.30, beats on revenue [10/28/2021 7:37 AM]	290.02	18.98 (7.00%)	272.46	1.42 (0.52%)	162.29 - 327.32	469,443	340,000	6,481
Repligen Q3 2021 Earnings Preview [10/27/2021 1:14 PM] Repligen EPS beats by $0.30, beats on revenue [10/28/2021 7:37 AM] Repligen shares rise after Q3 earnings beat, FY forecast raise [10/28/2021 10:21 AM] Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance [Oct-28-21 07:30AM] Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates [Oct-28-21 09:05AM] Repligen's (RGEN) Q3 Earnings & Sales Beat Estimates [Oct-28-21 08:34AM] Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript [Oct-28-21 04:01PM]
27-07-2021	PM	7:30 AM ET (Jul 27)	RGEN	Repligen Corporation	11,530	0.79	0.53	0.42	Repligen EPS beats by $0.27, beats on revenue [7/27/2021 7:34 AM]	226.42	20.41 (9.91%)	211.58	5.57 (2.70%)	135.23 - 228.84	1,013,527	340,000	2,634
Repligen Q2 Earnings Preview [7/26/2021 1:31 PM] Repligen EPS beats by $0.27, beats on revenue, guides FY2021 earnings above consensus [7/27/2021 7:34 AM] Repligen shares rise on Q2 earnings beat, FY forecast raise [7/27/2021 7:56 AM] Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance [Jul-27-21 07:30AM] Repligen (RGEN) Q2 Earnings and Revenues Surpass Estimates [Jul-27-21 08:45AM] Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript [Jul-27-21 02:00PM]
04-05-2021	PM	7:30 AM ET (May 4)	RGEN	Repligen Corporation	11,700	0.68	0.43	0.32	Repligen EPS beats by $0.25, beats on revenue; increases FY 2021 guidance [5/4/2021 7:36 AM]	194.67	-13.44 (-6.46%)	194.67	0.0 (0.00%)	109.38 - 228.84	563,060	270,000	3,904
Repligen EPS beats by $0.25, beats on revenue; increases FY 2021 guidance [5/4/2021 7:36 AM] Repligen shares rise on strong first-quarter results, FY forecast raise [5/4/2021 8:20 AM] Repligen Corp. to Host Earnings Call [May-04-21 06:45AM] Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance [May-04-21 07:30AM] Repligen Earnings Double As Sales Growth Accelerates; RGEN Stock Nears Buy Point [May-04-21 08:14AM] Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates [May-04-21 08:45AM] Repligen Snagged By Broader Market; Shares Tumble Despite Beat And Raise [May-04-21 11:13AM] Repligen (RGEN) Beats on Q1 Earnings & Sales, Raises 2021 View [May-04-21 12:20PM] Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript [May-04-21 02:00PM]
24-02-2021	PM	7:30 AM ET (Feb 24)	RGEN	Repligen Corporation	11,530	0.52	0.31	0.20	Repligen EPS beats by $0.21, beats on revenue [2/24/2021 7:31 AM]	215.75	9.24 (4.47%)	217.00	10.49 (5.08%)	78.41 - 228.84	521,084	324,385	1,435
Repligen EPS beats by $0.21, beats on revenue [2/24/2021 7:31 AM] Repligen Q4 Earnings Preview [2/23/2021 11:29 AM] Repligen Corp. to Host Earnings Call [Feb-24-21 06:30AM]
05-11-2020	PM	7:30 AM ET (Nov 5)	RGEN	Repligen Corporation	9,350	0.40	0.28	0.26	Repligen EPS beats by $0.11, beats on revenue [11/5/2020 7:36 AM]	201.86	14.99 (8.02%)	201.86	0.0 (0.00%)	78.41 - 203.90	678,821	350,525	714

30-07-2020	PM	7:30 AM ET (Jul 30)	RGEN	Repligen Corporation	7,170	0.42	0.28	0.31	Repligen EPS beats by $0.14, beats on revenue [7/30/2020 7:33 AM]	147.11	8.33 (6.00%)	145.60	6.82 (4.91%)	72.32 - 155.27	465,971	360,394	1,219

06-05-2020	PM		RGEN	Repligen Corporation	5,960	0.32	0.22	0.28	Repligen EPS beats by $0.07, beats on revenue [5/6/2020 7:31 AM]	114.52	0.58 (0.51%)	0.0	0.0 (0.00%)	65.20 - 123.81	336,011	542,140	0